Literature DB >> 19139230

Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity.

Beatriz Quiñones1, Shane Massey, Mendel Friedman, Michelle S Swimley, Ken Teter.   

Abstract

Escherichia coli O157:H7 is a leading cause of food-borne illness. This human pathogen produces Shiga toxins (Stx1 and Stx2) which inhibit protein synthesis by inactivating ribosome function. The present study describes a novel cell-based assay to detect Stx2 and inhibitors of toxin activity. A Vero cell line harboring a destabilized variant (half-life, 2 h) of the enhanced green fluorescent protein (d2EGFP) was used to monitor the toxin-induced inhibition of protein synthesis. This Vero-d2EGFP cell line produced a fluorescent signal which could be detected by microscopy or with a plate reader. However, a greatly attenuated fluorescent signal was detected in Vero-d2EGFP cells that had been incubated overnight with either purified Stx2 or a cell-free culture supernatant from Stx1- and Stx2-producing E. coli O157:H7. Dose-response curves demonstrated that the Stx2-induced inhibition of enhanced green fluorescent protein fluorescence mirrored the Stx2-induced inhibition of overall protein synthesis and identified a picogram-per-milliliter threshold for toxin detection. To establish our Vero-d2EGFP assay as a useful tool for the identification of toxin inhibitors, we screened a panel of plant compounds for antitoxin activities. Fluorescent signals were maintained when Vero-d2EGFP cells were exposed to Stx1- and Stx2-containing medium in the presence of either grape seed or grape pomace extract. The antitoxin properties of the grape extracts were confirmed with an independent toxicity assay that monitored the overall level of protein synthesis in cells treated with purified Stx2. These results indicate that the Vero-d2EGFP fluorescence assay is an accurate and sensitive method to detect Stx2 activity and can be utilized to identify toxin inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139230      PMCID: PMC2648150          DOI: 10.1128/AEM.02230-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  29 in total

Review 1.  Rapid laboratory identification and characterization of verocytotoxigenic (Shiga toxin producing) Escherichia coli (VTEC/STEC).

Authors:  K A Bettelheim; L Beutin
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

2.  ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

Authors:  Srdjan Jelacic; Cheryl L Wobbe; Daniel R Boster; Marcia A Ciol; Sandra L Watkins; Phillip I Tarr; Ann E Stapleton
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

3.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

5.  Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157:H7.

Authors:  Y Sugita-Konishi; Y Hara-Kudo; F Amano; T Okubo; N Aoi; M Iwaki; S Kumagai
Journal:  Biochim Biophys Acta       Date:  1999-10-18

6.  Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.

Authors:  K Ludwig; M A Karmali; V Sarkim; C Bobrowski; M Petric; H Karch; D E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation.

Authors:  Hiroshi Oi; Daisuke Matsuura; Masami Miyake; Masamiti Ueno; Izumi Takai; Takeshi Yamamoto; Masayoshi Kubo; Joel Moss; Masatoshi Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Structural characteristics of the plasmid-encoded toxin from enteroaggregative Escherichia coli.

Authors:  Patricia Scaglione; Kathleen N Nemec; Kaitlin E Burlingame; Agnieszka Grabon; Jazmin Huerta; Fernando Navarro-Garcia; Suren A Tatulian; Ken Teter
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

9.  Inhibition by apple polyphenols of ADP-ribosyltransferase activity of cholera toxin and toxin-induced fluid accumulation in mice.

Authors:  Takao Saito; Masami Miyake; Masamichi Toba; Hiroshi Okamatsu; Seiichi Shimizu; Masatoshi Noda
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

10.  Differential expression of receptors for Shiga and Cholera toxin is regulated by the cell cycle.

Authors:  Irina Majoul; Tobias Schmidt; Maria Pomasanova; Evgenia Boutkevich; Yuri Kozlov; Hans-Dieter Söling
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  28 in total

1.  Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen.

Authors:  Paul G Wahome; Yan Bai; Lori M Neal; Jon D Robertus; Nicholas J Mantis
Journal:  Toxicon       Date:  2010-03-27       Impact factor: 3.033

2.  Identification of Escherichia coli O157 by using a novel colorimetric detection method with DNA microarrays.

Authors:  Beatriz Quiñones; Michelle S Swimley; Amber W Taylor; Erica D Dawson
Journal:  Foodborne Pathog Dis       Date:  2011-02-02       Impact factor: 3.171

3.  Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay.

Authors:  Xiaohua He; Wenyuan Qi; Beatriz Quiñones; Stephanie McMahon; Michael Cooley; Robert E Mandrell
Journal:  Appl Environ Microbiol       Date:  2011-03-25       Impact factor: 4.792

4.  Deletion of eIF2β lysine stretches creates a dominant negative that affects the translation and proliferation in human cell line: A tool for arresting the cell growth.

Authors:  Gabrielle Dias Salton; Claudia Cilene Fernandes Correia Laurino; Nicolás Oliveira Mega; Andrés Delgado-Cañedo; Niclas Setterblad; Maryvonnick Carmagnat; Ricardo Machado Xavier; Elizabeth Cirne-Lima; Guido Lenz; João Antonio Pêgas Henriques; Jomar Pereira Laurino
Journal:  Cancer Biol Ther       Date:  2017-07-10       Impact factor: 4.742

5.  Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.

Authors:  Patrick Cherubin; Dennis Fidler; Beatriz Quiñones; Ken Teter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

6.  Top-down proteomic identification of Shiga toxin 2 subtypes from Shiga toxin-producing Escherichia coli by matrix-assisted laser desorption ionization-tandem time of flight mass spectrometry.

Authors:  Clifton K Fagerquist; William J Zaragoza; Omar Sultan; Nathan Woo; Beatriz Quiñones; Michael B Cooley; Robert E Mandrell
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

7.  An Environmental Shiga Toxin-Producing Escherichia coli O145 Clonal Population Exhibits High-Level Phenotypic Variation That Includes Virulence Traits.

Authors:  Michelle Qiu Carter; Beatriz Quinones; Xiaohua He; Wayne Zhong; Jacqueline W Louie; Bertram G Lee; Jaszemyn C Yambao; Robert E Mandrell; Michael B Cooley
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

8.  Catechin-mediated restructuring of a bacterial toxin inhibits activity.

Authors:  En Hyung Chang; Joanne Huang; Zixiang Lin; Angela C Brown
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-10-17       Impact factor: 3.770

9.  Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication.

Authors:  Shane Massey; Tuhina Banerjee; Abhay H Pande; Michael Taylor; Suren A Tatulian; Ken Teter
Journal:  J Mol Biol       Date:  2009-09-11       Impact factor: 5.469

Review 10.  Dietary Modulation of Bacteriophages as an Additional Player in Inflammation and Cancer.

Authors:  Luigi Marongiu; Markus Burkard; Sascha Venturelli; Heike Allgayer
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.